CCO Independent Conference Coverage: Clinical Impact of New Data From CROI 2017
Source: 2017 Conference on Retroviruses and Opportunistic Infections*

Module

In this Expert Analysis, Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, provide an in-depth discussion of the most clinically relevant new data on the management of patients with HIV infection presented at CROI 2017.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply data from studies of ARV agents used to prevent HIV infection
  • Devise management strategies based on the results of recent clinical studies of ARV agents in treatment-naive and treatment-experienced patients
  • Integrate best practices for managing complications associated with HIV, ART, and comorbidities

Topics covered include:

  • Introduction
  • Prevention of HIV Infection
  • New Data on Currently Available ART
  • ART Switch and Simplification Strategies
  • Investigational ARV Drugs
  • Treatment Complications and Comorbidities
 

Faculty

  • Joel E. Gallant
    MD, MPH
    Charles B. Hicks
    MD

Credit Information

  • Release Date:
    April 27, 2017
  • Expiration Date:
    April 26, 2018
  • Physicians:
    maximum of 1.0 AMA PRA Category 1 Credit
  • Registered Nurses:
    1.0 Nursing contact hour

Information on this Educational Activity

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Joel E. Gallant, MD, MPH


Medical Director of Specialty Services
Southwest CARE Center
Santa Fe, New Mexico
Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Joel E. Gallant, MD, MPH, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Gilead Sciences, Merck, Theratechnologies Inc., and ViiV and funds for research support from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Sangamo, and ViiV.
 

Charles B. Hicks, MD


Professor of Clinical Medicine
Director,
 Owen Clinic
University of California, San Diego
San Diego, California

Charles B. Hicks, MD, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Gilead, Janssen, Merck, and ViiV and royalties from UpToDate, Inc.
 

Staff

Jennifer M. Blanchette, PhD


Managing Editor

Jennifer M. Blanchette, PhD, has no real or apparent conflicts of interest to report.
 

Rachael M. Andrie, PhD


Clinical Editor

Rachael M. Andrie, PhD, has no real or apparent conflicts of interest to report.
 

Jenny Schulz, PhD


Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.
 

Edward King, MA


Executive Vice President

Edward King, MA, has no real or apparent conflicts of interest to report.
 

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles E. Willis, MBA, Director of Continuing Education, Amanda Sewell, MBA, Manager of Continuing Education, Debbie Price, Registration Database Administrator, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

 

Target Audience

This activity is intended for physicians, registered nurses, and other healthcare professionals involved in the care of patients at risk of or infected with HIV.


Goal

The goal of this activity is to improve participants’ competence in translating the most clinically significant data presented at CROI 2017 and other recent data into practical management strategies for individuals at risk of or infected with HIV infection.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply data from studies of ARV agents used to prevent HIV infection
  • Devise management strategies based on the results of recent clinical studies of ARV agents in treatment-naive and treatment-experienced patients
  • Integrate best practices for managing complications associated with HIV, ART, and comorbidities
 

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Nursing Continuing Education

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

1.0 contact hour may be earned for successful completion of this activity.

 

Commercial Support


This program is supported by educational grants from Gilead Sciences, Merck & Co., Inc., Theratechnologies Inc., and ViiV Healthcare.

 

Program Medium


This program has been made available online.

 

Site Requirements


  • Internet Explorer 7+, Firefox 3+, Safari 3+, or Chrome
  • JavaScript enabled
  • 1024x768+ screen resolution
  • Adobe Flash Player
 

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 27, 2017, through April 26, 2018:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.

  • My Take on New PrEP Data From CROI 2017

    Charles B. Hicks MD - 4/27/2017    1 comment / Last Comment: 5/9/2017
    PrEP offers an important option for curtailing HIV transmission. This review of new data from CROI emphasizes what management considerations must accompany its use.
  • How New Data From CROI 2017 May Inform Switch Strategies in HIV-Infected Patients With Poor Bone Health

    Charles B. Hicks MD - 4/21/2017    
    Is switching TDF to TAF justified in osteopenic women?
  • Optimizing HIV Care Engagement for a Newly Diagnosed Young Black Man

    Lisa Hightow-Weidman MD, MPH - 5/12/2017    
    In some cases, gaining trust may be the most important aspect of a patient’s care.
  • ART Switch for Comorbidities in a Middle-Aged Black Woman

    Lisa Hightow-Weidman MD, MPH - 5/12/2017    
    One-tablet regimens may not always be the best choice of ART, but the best choice is always the one the patient is willing to take.
  • Initiating ART in a Hispanic MSM With Fear of Stigma and History of Depression

    Lisa Hightow-Weidman MD, MPH - 5/12/2017    
    Understanding a patient’s life circumstances may be as important as any other aspect of providing good care.